UBS Group
ZEPP

UBS Group’s Zepp Health ZEPP Stock Holding History

UBS Group’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Sell
22,570
-11,753
-34% -$123K ﹤0.01% 7092
2026
Q1 		$410K Sell
34,323
-63,894
-65% -$1.31M ﹤0.01% 6216
2025
Q4 		$2.65M Sell
98,217
-83,085
-46% -$2.96M ﹤0.01% 4694
2025
Q3 		$8.3M Buy
181,302
+180,204
+16,412% +$5.46M ﹤0.01% 3501
2025
Q2 		$2.92K Buy
+1,098
New +$2.81K ﹤0.01% 9403
2024
Q3 		– Sell
-16,860
Closed -$40.5K – 10150
2024
Q2 		$40.5K Buy
16,860
+13,293
+373% +$43.2K ﹤0.01% 6851
2024
Q1 		$14.6K Buy
3,567
+3,479
+3,953% +$17.9K ﹤0.01% 7059
2023
Q4 		$497 Sell
88
-1
-1% -$5 ﹤0.01% 8629
2023
Q3 		$410 Buy
89
+1
+1% +$5 ﹤0.01% 8514
2023
Q2 		$399 Sell
88
-1,704
-95% -$8.59K ﹤0.01% 8256
2023
Q1 		$9.39K Sell
1,792
-743
-29% -$5.26K ﹤0.01% 7661
2022
Q4 		$14.7K Buy
+2,535
New +$13.6K ﹤0.01% 8053
2022
Q1 		– Sell
-1,625
Closed -$33K – 10999
2021
Q4 		$33K Buy
1,625
+1,559
+2,362% +$46.8K ﹤0.01% 7309
2021
Q3 		$2K Sell
66
-11
-14% -$454 ﹤0.01% 9004
2021
Q2 		$4K Sell
77
-533
-87% -$22.2K ﹤0.01% 8703
2021
Q1 		$26K Buy
610
+511
+516% +$29.7K ﹤0.01% 7139
2020
Q4 		$5K Buy
+99
New +$4.94K ﹤0.01% 7855
2020
Q3 		– Sell
-100
Closed -$5K – 8465
2020
Q2 		$5K Sell
100
-43
-30% -$1.98K ﹤0.01% 7395
2020
Q1 		$7K Buy
143
+43
+43% +$2.33K ﹤0.01% 7166
2019
Q4 		$5K Sell
100
-554
-85% -$23.2K ﹤0.01% 7604
2019
Q3 		$26K Buy
654
+383
+141% +$16.1K ﹤0.01% 6583
2019
Q2 		$11K Sell
271
-265
-49% -$11.1K ﹤0.01% 7034
2019
Q1 		$28K Buy
+536
New +$28.9K ﹤0.01% 6013
2018
Q4 		– Sell
-195
Closed -$8K – 8350
2018
Q3 		$8K Buy
+195
New +$7.85K ﹤0.01% 7295
2018
Q2 		– Sell
-145
Closed -$6K – 8305
2018
Q1 		$6K Buy
+145
New +$6.43K ﹤0.01% 7167

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

UBS Group's ZEPP Position: Q2 2026 in Review

UBS Group reduced its Zepp Health (ZEPP) stake by 34% in Q2 2026, selling an estimated $123K and leaving 22,570 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #7092.

UBS Group first reported a position in ZEPP in Q1 2018 and has held it in 25 quarters since. The position peaked at $8.3M in Q3 2025. 27 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • UBS Group held 22,570 shares of Zepp Health worth $118K as of Q2 2026.
  • UBS Group sold 11,753 Zepp Health shares in Q2 2026, an estimated $123K.
  • Zepp Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7092 holding.
  • UBS Group first reported a position in Zepp Health in Q1 2018 and has held it in 25 quarters since.
  • UBS Group's Zepp Health position peaked at $8.3M in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.